Hospital Gowns Market Size, Growth Analysis by Types, Applications and Global Opportunity

Global Hospital Gowns Market

Market Highlights:

According to MRFR analysis, the Global Hospital Gowns are expected to register a CAGR of 6.6% during the forecast period of 2020 to 2027 and reach USD 5.02 Billion by 2027.

A hospital gown is usually a short collarless gown that ties in the back, worn by patients being examined or treated in a doctor’s office, clinic, or hospital.

The growth of the hospital gowns market can be attributed to the growing need for personal protective equipment, due to the outbreak of COVID 19 globally and a rise in hospital-acquired infections.

Moreover, the increasing usage of disposable lab coats and hospital gowns for patients and increasing safety measures & hygiene by the government for the safety of patients& healthcare professionals, are expected to fuel the market growth during the forecast period.

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/9616

Surgical and disposable gowns are vital for protecting healthcare staff performing procedures on patients infected with the disease. Re-usage of hospital gowns and the availability of fake products are expected to restrain the growth of the global hospital gowns market. The Center for Disease and Prevention (CDC) issues recommendations for when and what personal protective equipment should be used to prevent exposure to infectious diseases.

Several market players such as Medline Industries, 3M, and Priontex among others are currently dominating the global hospital gowns market.

Key Players

Some of the key players in the global hospital gowns market are Medline Industries Inc. (US), Standard Textile Co. Inc. (US), Angelica Corporation (US), AmeriPride Services Inc. (US), Cardinal Health (US), 3M (US), Atlas Infiniti (India), Bellcross Industries Pvt. Ltd. (India), Priontex (South Africa), Sara Healthcare (India)

Regional Analysis

The market has been divided by region into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The hospital gowns market in Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. North America influences the global market for the hospital gowns market. The European hospital gowns market has been categorized as Western Europe and Eastern Europe. The Western Europe market has further been divided as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The global market of hospital gowns in Asia- Pacific has been segmented into Japan, China, India, Australia, South Korea, and Rest of Asia- Pacific. The Middle East and Africa hospital gowns market have been bifurcated as the Middle East and Africa.

Access Report Details @ https://www.marketresearchfuture.com/reports/hospital-gowns-market-9616

Segmentation:

The global hospital gowns market has been segmented based on type, risk type, and usability.

Based on type, the global hospital gowns market has been segmented into surgical, non-surgical, and patient gowns.

On the basis of risk type, the market has been segmented into minimal risk, low risk, moderate risk, and high risk.

Based on the usability the market has been segmented into disposable and reusable gowns.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

Hemifacial Spasm Market Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The US Uterine Fibroid Market report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

Global Merkel Cell Carcinoma Market Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth. Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...

Rohit Life-science Research

Search This Blog